Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme® in Canada, Australia, and New Zealand

Go back to Evolus Expands Strategic Partnership with Symatese to Commercialize Estyme® in Canada, Australia, and New Zealand
(NASDAQ: EOLS) Delayed: 8.98 +0.01 (0.11%)
Previous Close $8.97    52 Week High
Open $8.86    52 Week Low
Day High $9.08    P/E N/A 
Day Low $8.86    EPS
Volume 373,455